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Abstract 
Background: Angiopoietin-2 (Ang-2), a ligand of the Tie-2 receptor, plays an important role in maintaining endothe-
lial cells and in destabilizing blood vessels. Collateral artery growth (arteriogenesis) is a key adaptive response to 
arterial occlusion. It is unknown whether the destabilization of blood vessels by Ang-2 can affect arteriogenesis and 
modulate mononuclear cell function. This study aimed to investigate the effects of Ang-2 on collateral artery growth.
Methods: Hindlimb ischaemia model was produced in C57BL/6 mice by femoral artery ligation. Blood flow perfusion 
was measured using a laser Doppler perfusion imager quantitative RT-PCR analysis was applied to identify the level of 
angiogenic factors.
Results: After the induction of hindlimb ischaemia, blood flow recovery was impaired in mice treated with recombi-
nant Ang-2 protein; this was accompanied by a reduction of peri-collateral macrophage infiltration. In addition, quan-
titative RT-PCR analysis revealed that Ang-2 treatment decreased monocyte chemotactic protein-1 (MCP-1), platelet-
derived growth factor-BB (PDGF-BB) mRNA levels in ischaemic adductor muscles. Ang-2 can lead to macrophage 
M1/M2 polarization shift inhibition in the ischaemic muscles. Furthermore, Ang-2 reduced the in vitro inflammatory 
response in macrophages and vascular cells involved in arteriogenesis.
Conclusions: Our results demonstrate that Ang-2 is essential for efficient arteriogenesis, which controls macrophage 
infiltration.
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Background
Neovascularization is a complex process that involves 
vasculogenesis, angiogenesis, and arteriogenesis [1–3]. 
The principal stimuli for blood perfusion include tis-
sue ischaemia and hypoxia, inflammation, and vas-
cular shear stress. Angiogenesis is the growth of new 
blood vessels from pre-existing blood vessels, whereas 
arteriogenesis is the enlargement of existing blood 
vessels to form collaterals and requires the recruit-
ment of pro-inflammatory cells. A number of local 
and circulating angiogenic factors are involved in arte-
riogenesis, including vascular endothelial growth fac-
tor (VEGF), basic fibroblast growth factor (bFGF), and 
angiopoietins. Previous studies have demonstrated 
that angiopoietin-2 (Ang-2) regulates both angiogen-
esis and arteriogenesis [4], with the concentration of 
Ang-2 being an important determinant of which effect 
is observed. However, the role of Ang-2 in neovascu-
larization in vivo remains controversial [5–7] and needs 
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predominantly used transgenic mice to compare the 
effects of normal versus loss of Ang-2 expression on col-
lateral remodelling, relatively little is known about the 
impact of enhanced Ang-2 expression on this process.
There have been conflicting reports concerning the 
role of Ang-2 in postnatal neovascularization. For exam-
ple, Ang-2 was shown to increase the length, but not 
the density, of neovessels in a corneal implant model 
[8]. However, in a model of hindlimb ischaemia, collat-
eral formation was impaired in Ang-2 transgenic mice 
[6]. Moreover, still others have reported that the selec-
tive inhibition of Ang-2 activity promotes blood reper-
fusion following ischaemia through the recruitment of 
inflammatory cells and combination with VEGF [5, 9]. 
Finally, Ang-2 was shown to increase vascular destabili-
zation and regression by inhibiting pericyte recruitment 
and Tie-2–mediated phosphorylation of focal adhesion 
kinase [10–12]. However, no studies have implicated 
Ang-2 in controlling signalling pathways that initiate 
ischemia-mediated vessel stabilization and blood flow 
perfusion.
Therefore, we hypothesized that Ang-2 plays an impor-
tant role in the regulation of blood flow recovery during 
ischaemia through the modulation of collateral artery 
growth. In this study, we studied the effects of r-Ang-2 on 
blood flow perfusion and the density of pre-existing col-
lateral vessels in a murine hindlimb ischaemia model. We 
also studied post-ischaemic alterations in gene expression 
and macrophage recruitment to examine the potential 
mechanisms by which r-Ang-2 regulates arteriogenesis.
Methods
Mouse hindlimb ischaemia model
Male C57BL/6 mice were anaesthetized with sodium 
pentobarbital (60  mg/kg body weight, intraperitoneally) 
or isoflurane (5 % by inhalation) and administered a sin-
gle subcutaneous dose of buprenorphine hydrochloride 
(0.1 mg/kg) for analgesia. Additional sodium pentobarbi-
tal (12  mg/kg body weight) or 5  % isoflurane was given 
as needed to maintain anaesthesia. Mice were eutha-
nized by cervical dislocation at the end of the experiment 
while still anaesthetized. Mice were subjected to unilat-
eral hindlimb ischaemia as previously described [13]. 
Recombinant human Ang-2 (50 µg/mL) or vehicle (PBS) 
was injected intraperitoneally every other day beginning 
1  day before surgery. Real-time PCR was performed on 
mouse hindlimb muscles. In some experiments, mouse 
hindlimbs were also used for immunostaining. All proto-
cols for animal use were reviewed and approved by the 
Animal Care Committee of Southwest Medical Univer-
sity in accordance with Institutional Animal Care and 
Use Committee guidelines.
Laser Doppler perfusion images
The ratio of blood flow in the ischaemic (left) limb to the 
normoxic (right) limb was measured using a laser Dop-
pler perfusion imager (LDPI) (Moor Instruments, Devon, 
UK) as previously described [14, 15]. Non-invasive perfu-
sion imaging of the adductor thigh region and the plantar 
foot of both limbs was performed under 1.125 % isoflu-
rane/O2 anaesthesia at 37 ± 0.5  °C, before, immediately 
after, and at 1, 3, and 7  days following femoral artery 
ligation. Regions of interest were drawn to facilitate the 
analysis of specific anatomic regions. To minimize data 
variability caused by ambient light and temperature, the 
LDPI index was expressed as the ratio of left limb (ischae-
mic) to right limb (normoxic) blood flow.
Assessment of ischaemic muscles histology
Mice were euthanized 7  days after surgery. The ischae-
mic gastrocnemius muscles were excised, embedded in 
paraffin or TISSUE TEK OCT compound, and stored at 
−80  °C. Cross-sections were prepared for immunohis-
tochemical analysis. Capillary density was determined 
by immunostaining with anti-PECAM-1 antibody. The 
number of PECAM-1+ vessels was quantified in 5 micro-
scopic fields in each of 3 cross-sections from each tissue 
specimen using ImagePro Plus software. Adductor mus-
cle cryostat sections were obtained, and incubated with 
primary antibodies anti-Mac-3 (1:500, Pharmingen) and 
α-SMA (1:100, Santa Cruz Biotech). The secondary anti-
bodies used were goat ant-rat IgG AlexaFluor 488-con-
jugated antibody and goat ant-rabbit IgG AlexaFluor 
568-conjugated antibody (Molecular Probes, Invitro-
gen). Images were captured by a fluorescence microscopy 
(Leica).
In some experiments, cross-sections were stained with 
hematoxylin-eosin (HE). Photomicrographs were taken 
using a microscope (Leica), the collateral diameters were 
measured in 5 randomly selected fields per section. The 
mean value of these measurements was taken as a single 
point for each animal.
Quantitative real‑time PCR
Total RNA was extracted from hindlimb muscles using 
TRIzol (Invitrogen). RNA was pre-treated with deoxy-
ribonuclease I (Invitrogen Life Technologies), and a 
SuperScript kit (Invitrogen Life Technologies) was used 
to synthesize cDNA according to the manufacturer’s rec-
ommendations. Each sample was analysed in duplicate 
with ribosomal 18S RNA used as an internal control. All 
fold changes in gene expression were determined using 
the 2−ΔΔCT method. The values are presented as the 
mean ± SEM. All primers are listed in Additional file 1: 
Table S1.
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Migration assay
Macrophages were obtained by flushing the peritoneal 
cavity with phosphate-buffered saline (PBS) 4 days after 
intraperitoneal injection with 1 mL of a 3 % thioglycollate 
solution (Difco Laboratories, Sparks, MD). Macrophage 
migration assays were performed using transwell migra-
tion chambers with 8.0-μm porous membranes (Corning 
Costar, Corning, NY, USA). Cells (2 ×  104) were added 
to the upper chambers and were treated with r-Ang-2 
(200  nmol/L) or vehicle control. In some experiments, 
cells were pre-treated with r-Ang-2 for 30 min, followed 
by stimulation with MCP-1 (100  ng/mL). After incuba-
tion for 24 h at 37 °C in a humidified chamber with 5 % 
CO2, the porous membranes were rinsed, and the cells 
remaining in the upper chamber were removed with a 
cotton swab. The membranes were then fixed and stained 
with 0.5  % crystal violet. The cells that had migrated to 
the lower chamber were counted.
The migration of human coronary artery smooth 
muscle cells (VSMCs) was measured using a previ-
ously described method [16]. Briefly, cells were grown 
to confluence on 6-well plates. Parallel lines were then 
drawn with a marker on the back of each well, and lin-
ear wounds were made perpendicular to these lines in the 
cell monolayers by scraping each well with a sterile 200-
µL pipette tip. Cells were then rinsed twice with serum-
free medium to remove cellular debris. Images of the 
intersections between the parallel lines and wounds were 
obtained using an Olympus inverted microscope. The 
cells were then incubated with or without Ang-2 (200 ng/
mL) for 30 min in the presence or absence of PDGF-BB 
(20 ng/mL). After 12 h, images of each intersection were 
obtained again. ImageJ software was then used to meas-
ure the distance between the two edges of each wound. 
The data are presented as the moving distance, which is 
the difference in the distances between the two edges at 
the same crossing at 0 and 12 h.
Enzyme‑linked immunosorbent assay
A human Ang-2 ELISA kit (R&D Systems) was used 
to quantify Ang-2 according to the manufacturer’s 
instructions.
Statistical analysis
The data are expressed as the mean  ±  SEM of at least 
triplicate experiments. Groups were compared using the 
two-tailed Student’s t test.
Results
r‑Ang‑2 impaired blood reperfusion following ischaemia
Hindlimb ischaemia was induced in C57BL/6 mice by 
ligation and excision of the femoral artery, after which 
mice received either r-Ang-2 or vehicle control.
To analyse circulating levels of Ang-2, mice were 
injected with recombinant protein, and plasma was col-
lected after 7 days of treatment, and analyzed by ELISA. 
Intraperitoneal injections of r-Ang-2 showed that human 
Ang-2 (81.9 ± 8.08 ng/mL) was detectable in the plasma. 
r-Ang-2 was not detectable in both nonischemic and 
ischemic adductor muscles (data not shown). When we 
measured overall hindlimb blood flow, there were no 
significant differences in plantar foot perfusion between 
r-Ang-2- and vehicle control-treated mice (Fig.  1a, b). 
In addition, the PECAM-1+  capillary density in ischae-
mic gastrocnemius muscles did not differ significantly 
between the experimental groups (Fig.  1e, f ).We next 
measured blood perfusion in the adductor region, which 
contains pre-existing collateral arterioles that supply the 
lower limb. Laser Doppler imaging revealed that reper-
fusion of ischaemic hindlimb tissue after femoral artery 
ligation was significantly reduced in r-Ang-2-treated 
mice compared with vehicle controls (Fig. 1c, d). Consist-
ent with these results, the ratio of mean arteriole diam-
eter in Ang-2 group to vehicle in ischaemic adductor 
muscles of r-Ang-2-treated mice 7 days after induction of 
ischaemia was significantly smaller than in vehicle con-
trol-treated animals (Fig. 1g, h).
r‑Ang‑2 suppresses the infiltration of inflammatory cells
To determine whether r-Ang-2 treatment could be 
related to inflammatory cell infiltration in ischaemia, 
we examined the infiltration of macrophages in ischae-
mic adductor muscles. The infiltration of macrophages 
around sites of arteriogenesis in ischaemic hind limbs 
was determined by immunostaining with the anti-Mac3 
antibody. Treatment with r-Ang-2 caused a marked 
reduction in the infiltration of macrophages surrounding 
collateral arterioles in ischaemic adductor muscles 7 days 
post-femoral ligation (Fig. 2a). We next performed quan-
titative RT-PCR to study the effects of r-Ang-2 on mac-
rophage polarization of ischemic muscles. Macrophage 
phenotype was characterized by examining expression of 
specific pro-inflammatory M1 (CD11c) and anti-inflam-
matory M2 (CD206) macrophage markers using real-time 
PCR. After 7 days of ischemia, both CD11c mRNA and 
CD206 mRNA expression were significantly downregu-
lated in ischemic adductor muscles from r-Ang-2-treated 
mice compared with vehicle-treated mice (5.33  ±  0.78 
vs. 13.66 ± 1.31 for CD11c; 1.83 ± 0.34 vs. 2.73 ± 0.36 
for CD206; respectively, P < 0.05 for all) (Fig. 2b, c).The 
ratio of CD11c to CD206 (index of M1/M2 macrophage 
balance) was significantly lower in r-Ang-2-treated mice 
than n vehicle-treated mice (3.15 ± 0.79 vs. 5.24 ± 1.17; 
P < 0.05) (Fig. 2d).
To further study the effects of r-Ang-2 on mac-
rophage migration, we isolated thioglycollate-elicited 
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macrophages from C57BL/6  mice and used a modi-
fied Boyden chamber assay that required macrophages 
to migrate through a porous membrane. In the absence 
of adding Ang-2, MCP-1 significantly stimulated mac-
rophage migration. However, pre-treatment with r-Ang-2 
abrogated MCP-1-induced migration, whereas treatment 
with Ang-2 alone did not significantly alter macrophage 
migration (Fig.  2e, f ).These results supported the func-
tional significance of r-Ang-2 by inhibiting pericollateral 
macrophage recruitment.
r‑Ang‑2 modulates post‑ischaemic gene regulation
H&E staining showed reduced mean arteriole diameter 
in the adductor muscles from the r-Ang-2-treated group 
compared to the vehicle control group. To study differen-
tial gene expression after r-Ang-2 treatment, total RNA 
isolated from the adductor muscle was used to assess the 
gene expression levels of angiogenesis-related factors and 
their receptors. Quantitative real-time RT-PCR analysis 
revealed that the expression of PDGF-BB, VEGF-A and 
VEGF -C, angiopoietin-1 (Ang-1), and its receptor, Tie-2, 
was downregulated in the adductor muscles of r-Ang-2-
treated mice (1.00 ± 0.19 vs. 0.46 ± 0.12 for PDGF-BB; 
1.00 ± 0.18 vs. 0.21 ± 0.03 for VEGF-A; 1.00 ± 0.19 vs. 
0.32 ± 0.05 for VEGF-C; 1.00 ± 0.07 vs. 0.09 ± 0.02 for 
angiopoietin-1; 1.00  ±  0.14 vs. 0.34  ±  0.11 for Tie-2; 
respectively, P < 0.05 for all) (Fig. 3). Additionally, MCP-1 
has been shown to be downregulated after r-Ang-2 treat-
ment and is known to be involved in the process of col-
lateral formation (1.00 ± 0.08 vs. 0.19 ± 0.03; P < 0.05) 
(Fig. 3). These results suggest that angiogenesis is severely 
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Fig. 1 r-Ang-2 impaired blood flow perfusion during ischaemia. a Representative laser-Doppler images of the plantar foot at the indicated time 
points after femoral artery ligation. “Pre” and “Post” are immediately before and after surgery, respectively. b The mean blood flow ratio of ischae-
mic to non-ischaemic hindlimb foot pads for all animals at indicated time points (n = 6/group; *P < 0.05 vs. the r-Ang-2 groupat 5 and 7 days). c 
Representative laser-Doppler images of the adductor region at the indicated time points after femoral artery ligation. “Pre” and “Post” are immedi-
ately before and after surgery, respectively. Outlined areas shown the regions of interest. d The mean blood flow ratio in ischaemic to non-ischaemic 
hindlimb footpads for all animals at the indicated time points (n = 6/group; *P < 0.05 vs. r-Ang-2 group at 5 and 7 days). e Representative images 
of PECAM-1+ capillaries in ischaemic gastrocnemius muscles 7 days after femoral artery ligation. Scale bars 100 μm. f Mean capillary density in 
ischaemic gastrocnemius muscles assessed by PECAM-1 immunostaining. g Representative images of collateral arterioles in ischaemic adductor 
muscles, assessed using H&E staining. h The ratio of mean arteriole diameter in Ang-2 group to vehicle in ischaemic adductor muscles (n = 6/
group; *P < 0.05 vs. vehicle)
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Effects of r‑Ang‑2 on in vitro VSMC migration
Because we observed a decreased arteriole diameter in 
ischaemic adductor muscles in response to in vivo Ang-2 
treatment, we studied the effect of Ang-2 on VSMCs 
migration in  vitro using a 2-dimensional scratch assay. 
To determine if Ang-2 exhibits differential effects on 
VSMCs, we treated cultured human coronary artery 
smooth muscle cells with PDGF-BB. PDGF-BB sig-
nificantly induced VSMCs migration, with maximal 
increases observed after 12 h of exposure. However, pre-
treatment with Ang-2 attenuated the capacity of PDGF-
BB to induce VSMC migration (Fig. 4). Furthermore, in 
the absence of added PDGF-BB, Ang-2 had no significant 
effects on migration (Fig.  4). These results further sup-
port the assertion that Ang-2 inhibits the recruitment of 
VSMCs.
Discussion
In this study, we assessed the role of Ang-2 in arterio-
genesis using a mouse hindlimb ischaemia model. Our 
findings indicate that Ang-2 reduced the diameter of col-
lateral arterioles in ischaemic adductor muscles following 
ligation of the femoral artery. This change is associated 
with reductions in arteriogenesis but leaves angiogenesis 
intact. Furthermore, we found that Ang-2 reduced MCP-
1-induced macrophage migration and PDGF-BB-induced 
VSMC migration in  vitro. Therefore, we conclude that 
Ang-2 is important for arteriogenesis induced by acute 
loss of hindlimb perfusion.
The angiopoietin/Tie system is essential for vascular 
development and maturation [17]. Ang-1/Tie-2 signal-
ling promotes blood vessel stabilization and the recruit-
ment of mural cells, whereas Ang-2 acts as an Ang-1 
antagonist and destabilizes vessels [18, 19]. However, 
the complex role of Ang-2 in vascular remodelling still 
remains unknown. We found that treatment with r-Ang-2 
impaired the recovery of blood flow in the ischaemic 
hindlimb, suggesting that Ang-2 is involved in collateral 
artery growth after arterial ligation. However, effects of 
Ang-2 in hindlimb ischaemia remain controversial. For 
example, Tressel et  al. showed that the Ang-2 inhibitor, 
L1-10, induced in ischemic tissue plays a critical role in 
blood flow recovery by stimulating inflammation and arte-































































































Fig. 2 r-Ang-2 suppresses inflammatory cell infiltration. a Recruitment of macrophages in response to ischaemia as determined by Mac-3 staining. 
Representative images of macrophages surrounding collateral arterioles in ischaemic adductor muscles in r-Ang-2 treated-mice on day 7 after 
femoral artery ligation are shown. b mRNA expression of CD11c (M1 marker), and c mRNA expression of CD206 (M2 marker) in ischemic adductor 
muscles as measured by real-time PCR. d Ratio of CD11c to CD206, The data were normalized to the expression level of 18S rRNA in each sample. 
All values represent the mean ± SEM (n = 6/group). *P < 0.05 vs. vehicle control. e Thioglycollate-elicited mouse peritoneal macrophages were 
used to evaluate macrophage migration. Cells were added to the upper chambers of cell culture inserts and incubated with Ang-2 (200 ng/mL) or 
vehicle control and then treated with MCP-1 (100 ng/mL) or vehicle control as indicated. Representative images of macrophages that migrated to 
lower-chamber side of transwell membrane. f The data represent the mean of triplicate experiments. *P < 0.05 vs. negative control (cells exposed 
neither MCP-1 nor Ang-2). **P < 0.05 vs. macrophages incubated with MCP-1 only
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overexpression of Ang-2 impaired revascularization dur-
ing hindlimb ischaemia. The importance of local vari-
ations in Ang-2 concentration might be an important 
determinant of whether vessel growth or regression 
occurs [6]. Our findings with r-Ang-2 in this study are in 
agreement with another murine study of Ang-2 overex-
pression and support the in vivo relevance of Ang-2-me-
diated destabilization of collateral arteries. We did not 
observe an increase in capillary density in ischaemic gas-
trocnemius muscle in response to r-Ang-2 treatment. In 
addition, our finding that the expression of several major 
growth factors was transiently downregulated following 
Ang-2 treatment further supports the initial role of Ang-2 
in neovascularization. However, Ang-2 exhibits an oppos-
ing role regulating angiogenesis through its receptor Tie-2 
and integrin signalling [12]. Thus, these data suggest that 
Ang-2 mediates blood flow recovery mainly through arte-
















































































































































Fig. 3 r-Ang-2 modulates post-ischaemic gene regulation. mRNA expression levels of angiopoietin-1, Tie-2, PDGF-BB, VEGF-A, VEGF-C, and MCP-1 
were analysed using real-time PCR in ischaemic adductor muscles. The data were normalized to the expression level of 18S rRNA in each sample. All 
values represent the mean ± SEM (n = 6/group). *P < 0.05 vs. vehicle control






















Fig. 4 Effects of r-Ang-2 on VSMC migration in vitro. Migration of 
human coronary artery smooth muscle cells in the presence of r-Ang-
2, followed by treatment with PDGF-BB (20 ng/mL) or vehicle control 
was studied. The data represent the mean of triplicate experiments. 
*P < 0.05 vs. negative control. **P < 0.05 vs. cells incubated with 
PDGF-BB only
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The reduced diameter of collateral arterioles in ischae-
mic adductor muscles in mice treated with r-Ang-2 could 
be the result of inhibited mural cell recruitment. How-
ever, it is unclear whether Ang-2 has a direct effect on 
the recruitment of VSMCs and pericytes [20]. A recent 
study showed that Ang-2 induced pericyte apoptosis via 
α3β1 integrin signalling in a model of diabetic retinopa-
thy [21]. In the present study, we further evaluated the 
effect of Ang-2 on VSMC migration. In the absence of 
exogenous Ang-2, PDGF-BB significantly enhanced the 
migration of VSMCs. However, in the absence of exog-
enous PDGF-BB, Ang-2 did not significant impact migra-
tion. The inhibitory effect of Ang-2 could be mediated by 
the uncoupling of PDGF receptor-β (PDGFR-β)-integrin 
crosstalk, as has been described [20, 22]. This mechanism 
was not resolved in our experiments. Additional stud-
ies are necessary to more precisely define the molecular 
events underlying Ang-2-mediated, integrin-dependent 
downregulation of PDGFR-β signalling.
There is evidence that Ang-2 acts as a chemoattract-
ant for regulating monocyte/macrophage infiltration [5, 
23], suggesting that treatment with r-Ang-2 may increase 
macrophage recruitment to remodelling collateral arteri-
oles. However, our data did not support this mechanism 
because we observed reduced macrophage content in 
ischaemic adductor muscles in  vivo. Moreover, Ang-2 
treatment abrogated MCP-1-induced macrophage migra-
tion in  vitro, whereas treatment with Ang-2 alone had 
no significant effects on migration. In the present study 
demonstrate that Ang-2 can lead to M1/M2 shift inhibi-
tion in the ischemic muscles. Our data suggest that Ang-
2-mediated reductions in MCP-1 may impair monocyte 
recruitment and, therefore, arteriogenesis.
A limitation to the present study is that we cannot at 
this time definitively determine the inhibitory effect of 
Ang-2 on arteriogenic activity depends on macrophages 
compared with pericytes. Additionally, we only detected 
the effect of Ang-2 at this early time point. Future stud-
ies are required in which monocyte/macrophage popu-
lations are depleted and late adaptive responses to hind 
limb ischaemia assessed. In addition, cross-breeding of 
Apo E knockout mice with Ang-2 knockout or Ang-2 
transgenic mice will provide additional evidence for the 
role of Ang-2 in atherogenesis. Despite these limitations, 
we believe our study provides a preliminary results of 
Ang-2 involved in the complex processes contributing to 
collateral formation.
Conclusions
We found that Ang-2-treated mice exhibited impaired 
collateral remodelling after femoral artery ligation, as 
well as a reduction in the diameter of pre-existing col-
laterals. Ang-2 treatment also altered the expression of 
several growth factor genes and reduced pro-arteriogenic 
inflammatory responses. These findings indicate that 
Ang-2 could be a key regulator of post-ischaemic blood 
flow recovery by inhibiting the inflammatory factors 
required for arteriogenesis, and this may lead to potential 
therapeutic strategies for managing ischaemic cardiovas-
cular diseases.
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